Diffusion Pharmaceuticals, Inc. reported raising $15.8M in a private placement filing on March 16, 2017

Mar 18, 2017
Background Information
Diffusion Pharmaceuticals, Inc. is a clinical stage company, which engages in the development of treatment for life threatening conditions. It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.